Evidence map›Paper›PMID 39022051›Full record

ArticleHeliyon2024

Many-objective ant lion optimizer (MaOALO): A new many-objective optimizer with its engineering applications.

Kanak Kalita, Sundaram B Pandya, Robert Čep, Pradeep Jangir, Laith Abualigah

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kanak KalitaDepartment of Mechanical Engineering, Vel Tech Rangarajan Dr. Sagunthala R&D Institute of Science and Technology, Avadi, 600 062, India.
Sundaram B PandyaDepartment of Electrical Engineering, Shri K.J. Polytechnic, Bharuch, 392 001, India.
Robert ČepDepartment of Machining, Assembly and Engineering Metrology, Faculty of Mechanical Engineering, VSB-Technical University of Ostrava, 70800, Ostrava, Czech Republic.
Pradeep JangirDepartment of Biosciences, Saveetha School of Engineering. Saveetha Institute of Medical and Technical Sciences, Chennai, 602 105, India.
Laith AbualigahComputer Science Department, Al Al-Bayt University, Mafraq, 25113, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many-objective optimization (MaO) is an important aspect of engineering scenarios. In many-objective optimization algorithms (MaOAs), a key challenge is to strike a balance between diversity and convergence. MaOAs employs various tactics to either enhance selection pressure for better convergence and/or implements additional measures for sustaining diversity. With increase in number of objectives, the process becomes more complex, mainly due to challenges in achieving convergence during population selection. This paper introduces a novel Many-Objective Ant Lion Optimizer (MaOALO), featuring the widely-popular ant lion optimizer algorithm. This method utilizes reference point, niche preserve and information feedback mechanism (IFM), to enhance the convergence and diversity of the population. Extensive experimental tests on five real-world (RWMaOP1- RWMaOP5) optimization problems and standard problem classes, including MaF1-MaF15 (for 5, 9 and 15 objectives), DTLZ1-DTLZ7 (for 8 objectives) has been carried out. It is shown that MaOALO is superior compared to ARMOEA, NSGA-III, MaOTLBO, RVEA, MaOABC-TA, DSAE, RL-RVEA and MaOEA-IH algorithms in terms of GD, IGD, SP, SD, HV and RT metrics. The MaOALO source code is available at: https://github.com/kanak02/MaOALO.

Indexed as

Ant lion optimizerConvergenceDiversityMaF benchmarkMany-objective optimization

Identifiers

PMID39022051
PMCPMC11253286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.